Mission Bay Capital Management, Inc.

Mission Bay Capital Management, Inc.

Mission Bay Capital Management, Inc.

Date Founded



1700 4th Street,Suite 214,San Francisco, CA 94158-2330

Type of Company


Employees (Worldwide)

1 - 10


Private Equity & Venture Capital
Investment Services & Portfolio Management

Company Description

Mission Bay Capital Management focuses on seed-stage investments in bioscience companies emerging from research activities at the University of California.

Contact Data
Trying to get in touch with decision makers at Mission Bay Capital Management, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Managing Partner

Managing Partner

Managing Partner


Mbc Archangel Advisor

Entrepreneurship Program Manager, Qb3

Paths to Mission Bay Capital Management, Inc.
Potential Connections via
Relationship Science
Mission Bay Capital Management, Inc.
Recent Transactions
Details Hidden

Gilead Sciences, Inc. purchases Cell Design Labs, Inc. from Kleiner Perkins Caufield & Byers LLC, Osage Partners LLC, Mission Bay Capital Management, Inc.

Details Hidden

Bio-Techne Corp. purchases Zephyrus Biosciences, Inc. from Life Science Angels, WS Investment Management Co., Mission Bay Capital Management, Inc., Stanford University (Venture Capital)

Details Hidden

Catalent Pharma Solutions, Inc., The Blackstone Group, Inc. purchase Redwood Bioscience, Inc. from Takeda Ventures, Inc., Mission Bay Capital Management, Inc.

Details Hidden

Magnamosis, Inc. develops medical devices. The company was founded in 2012 and is headquartered in San Francisco, CA.

Details Hidden

Redwood Bioscience Inc. develops precision protein-chemical engineering technology to produce the next-generation of antibody-drug conjugates and other semi-synthetic biotherapeutics. It employs natural post translational modifications found in human cells to site specifically create one or more aldehyde tags on protein molecules, including monoclonal antibodies. The firm's platform is enabled with precision chemistries, payload positioning and defined stoichiometry of payload protein ratios. The company was founded by Carolyn R. Bertozzi, Mike Blank and David Rabuka in 2008 and is headquartered in Emeryville, CA.

Details Hidden

Glycomine, Inc. engages in the development of therapeutics for diseases which have no treatment options. Its therapeutic approach is to combine replacement therapies such as substrates, enzymes, or proteins with intracellular delivery vehicles consisting of bio-nanomaterials or ligands that target the molecules to the cell interior of clinically relevant organs. It focuses on research of mannose-1-phosphate and Ngly1 enzyme replacement therapy, and observational study of GLY-000. The company was founded in 2014 by Agnes Rafalko and is headquartered in San Carlos, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Mission Bay Capital Management, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Mission Bay Capital Management, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Mission Bay Capital Management, Inc..